AstraZeneca PLC (AZN)

NYSE: AZN · Real-Time Price · USD

172.48

+2.84 (1.67%)

At close: Jul 28, 2026, 4:00 PM EDT

171.00

-1.48 (-0.86%)

After-hours: Jul 28, 2026, 7:54 PM EDT

AstraZeneca Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	267,012	272,184	201,571	208,419	211,114	179,498
Market Cap Growth	18.54%	35.03%	-3.29%	-1.28%	17.61%	35.39%
Enterprise Value	294,544	296,117	226,297	231,102	233,962	203,900
Last Close Price	172.48	175.50	130.00	134.45	136.22	115.85

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	25.56	26.83	28.89	35.29	64.56	1448.13
PS Ratio	4.35	4.63	3.73	4.55	4.76	4.80
PB Ratio	5.30	5.59	4.94	5.32	5.70	4.57
P/FCF Ratio	25.03	23.14	20.28	23.20	24.22	36.84
P/OCF Ratio	19.49	18.67	16.99	20.15	21.52	30.10

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.80	5.04	4.19	5.04	5.28	5.45
EV/EBITDA Ratio	14.49	15.20	13.56	17.02	25.33	26.88
EV/EBIT Ratio	21.08	21.55	22.62	28.21	62.27	193.09
EV/FCF Ratio	27.61	25.17	22.77	25.72	26.84	41.85

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.52	0.54	0.68	0.59	0.64	0.74
Debt / EBITDA Ratio	1.59	1.52	1.82	2.11	3.17	4.06
Debt / FCF Ratio	3.02	2.52	3.05	3.19	3.35	6.32
Net Debt / Equity Ratio	0.54	0.49	0.60	0.58	0.62	0.62
Net Debt / EBITDA Ratio	1.34	1.23	1.48	1.67	2.47	3.21
Net Debt / FCF Ratio	2.56	2.03	2.48	2.52	2.62	5.01
Asset Turnover	0.53	0.54	0.53	0.46	0.44	0.43
Inventory Turnover	1.65	1.80	1.91	1.63	1.81	1.91
Quick Ratio	0.61	0.68	0.67	0.59	0.64	0.71
Current Ratio	0.89	0.94	0.93	0.82	0.86	1.16
Return on Equity (ROE)	21.10%	22.84%	17.59%	15.64%	8.63%	0.42%
Return on Assets (ROA)	10.09%	10.40%	7.90%	7.16%	4.90%	-0.53%
Return on Invested Capital (ROIC)	15.34%	16.42%	12.73%	11.63%	8.01%	-1.00%
Return on Capital Employed (ROCE)	16.66%	17.22%	13.63%	11.64%	4.91%	1.63%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	3.91%	3.73%	3.46%	2.83%	1.55%	0.07%
FCF Yield	4.00%	4.32%	4.93%	4.31%	4.13%	2.71%
Dividend Yield	1.87%	1.83%	2.30%	2.15%	2.07%	2.35%
Payout Ratio	48.35%	48.62%	65.80%	75.25%	132.72%	3442.86%
Buyback Yield / Dilution	0.03%	0.06%	-0.06%	-0.13%	-9.32%	-8.68%
Total Shareholder Return	1.91%	1.89%	2.23%	2.02%	-7.25%	-6.34%

SEC Filings: 10-K · 10-Q